HomeInsightsStock Comparison

Astrazeneca Pharma India Ltd vs Source Natural Foods Herbal Supplements Ltd Stock Comparison

Astrazeneca Pharma India Ltd vs Source Natural Foods Herbal Supplements Ltd Stock Comparison

Last Updated on: May 10, 2025

Key Highlights

  • The Latest Trading Price of Astrazeneca Pharma India Ltd is ₹ 7992 as of 09 May 15:30.
  • The P/E Ratio of Astrazeneca Pharma India Ltd changed from 82.8 on March 2020 to 82.4 on March 2024 . This represents a CAGR of -0.10% over 5 yearsThe P/E Ratio of Source Natural Foods & Herbal Supplements Ltd changed from 28.4 on March 2020 to 32.7 on March 2024 . This represents a CAGR of 2.86% over 5 years.
  • The Market Cap of Astrazeneca Pharma India Ltd changed from ₹ 5978 crore on March 2020 to ₹ 13301 crore on March 2024 . This represents a CAGR of 17.34% over 5 yearsThe Market Cap of Source Natural Foods & Herbal Supplements Ltd changed from ₹ 46.54 crore on March 2020 to ₹ 56.75 crore on March 2024 . This represents a CAGR of 4.05% over 5 years.
  • The revenue of Astrazeneca Pharma India Ltd for the Dec '24 is ₹ 448.27 crore as compare to the Sep '24 revenue of ₹ 416.15 crore. This represent the growth of 7.72% The revenue of Source Natural Foods & Herbal Supplements Ltd for the Dec '24 is ₹ 10.45 crore as compare to the Sep '24 revenue of ₹ 10.26 crore. This represent the growth of 1.85%.
  • The ebitda of Astrazeneca Pharma India Ltd for the Dec '24 is ₹ 51.42 crore as compare to the Sep '24 ebitda of ₹ 60.69 crore. This represent the decline of -15.27% The ebitda of Source Natural Foods & Herbal Supplements Ltd for the Dec '24 is ₹ 1.67 crore as compare to the Sep '24 ebitda of ₹ 1.37 crore. This represent the growth of 21.9%.
  • The net profit of Astrazeneca Pharma India Ltd changed from ₹ 53.86 crore to ₹ 30.85 crore over 7 quarters. This represents a CAGR of -27.27% The net profit of Source Natural Foods & Herbal Supplements Ltd changed from ₹ 0.27 crore to ₹ 1.02 crore over 7 quarters. This represents a CAGR of 113.72% .
  • The Dividend Payout of Astrazeneca Pharma India Ltd changed from 3.46 % on March 2020 to 37.15 % on March 2024 . This represents a CAGR of 60.76% over 5 yearsThe Dividend Payout of Source Natural Foods & Herbal Supplements Ltd changed from 39.26 % on March 2020 to 0 % on March 2024 . This represents a CAGR of -100.00% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Astrazeneca Pharma India Ltd

  • AstraZeneca Pharma India Limited (APIL) was incorporated on July 11, 1979.
  • The Company is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and co-ordinates clinical trial services with an overseas group company.
  • The major therapy areas where the company operates are Onocology, Alimentary & Metabolism, Cardio Vascular, Renal, Diabetes, Respiratory and Oncology. AstraZeneca Pharma India, formerly known as Astra-IDL (AIL), was an erstwhile joint venture of Astra Zeneca, UK and Hinduja controlled IDL. Astra Pharmaceuticals AB, Sweden acquired all of the 1287500 equity shares in the Company of IDL, representing 25.75% of the Company's issued and paid up equity share capital.
  • Consequently, the Company became a subsidiary of Astra, which is a direct wholly owned subsidiary of Astra AB, Sweden (now known as AstraZeneca Pharmaceuticals AB Sweden) and an indirect wholly owned subsidiary of AstraZeneca Plc, the Group parent Company.

About Source Natural Foods & Herbal Supplements Ltd

  • Source Natural Foods &Herbal Supplements Limited was formerly incorporated as Inwinex Pharmaceuticals Limited in 1995.
  • The Company name was then changed from Inwinex Pharmaceuticals Limited to Source Natural Foods &Herbal Supplements Limited in 2011-12.
  • The Company engages in the pharmaceutical business in India.
  • It provides allopathic and ayurvedic formulations.
  • Its principal products include Organic Ashwagandha, Organic Triphala, and Organic Satavari Tablets. Company operates in the Ayurveda and herbal sphere which has been identified as one of the key sectors of growth and innovation for the Country.

Astrazeneca Pharma India Ltd News Hub

News

AstraZeneca Pharma gets CDSCO nod to import and distribute TAGRISSO (Osimertinib)

The newly approved indication allows Osimertinib to be used in combination with pemetrexed...

Read more

05 Apr 2025 14:43

News

Astrazeneca Pharma gains after receiving approval from CDSO to import Durvalumab solution.

Through this approval, Durvalumab in combination with Tremelimumab is indicated for the tr...

Read more

03 Mar 2025 14:43

News

Astrazeneca Pharma gains after Q3 PAT soars to Rs 55 cr

Revenue from operations jumped 44% to Rs 440.29 crore in Q3 FY25 as compared with Rs 305.7...

Read more

12 Feb 2025 11:47

News

Astrazeneca Pharma India to hold board meeting

Astrazeneca Pharma India will hold a meeting of the Board of Directors of the Company on 1...

Read more

21 Jan 2025 10:45

News

Volumes spurt at Astrazeneca Pharma India Ltd counter

Happiest Minds Technologies Ltd, Campus Activewear Ltd, Cera Sanitaryware Ltd, ITI Ltd are...

Read more

30 Dec 2024 14:30

News

AstraZeneca gets CDSCO nod to import cancer drug, Lynparza

This approval establishes the use of Olaparib in combination with Durvalumab as a maintena...

Read more

26 Nov 2024 14:49

Source Natural Foods & Herbal Supplements Ltd News Hub

News

Source Natural Foods &Herbal Supplem. to table results

Source Natural Foods &Herbal Supplem. will hold a meeting of the Board of Directors of the...

Read more

07 Feb 2025 16:52

News

Source Natural Foods &Herbal Supplem. to declare Quarterly Result

Source Natural Foods &Herbal Supplem. will hold a meeting of the Board of Directors of the...

Read more

11 Nov 2024 13:01

News

Source Natural Foods &Herbal Supplem. to hold AGM

Source Natural Foods &Herbal Supplem. announced that the 29th Annual General Meeting (AGM)...

Read more

23 Sep 2024 09:42

News

Source Natural Foods &Herbal Supplem. announces board meeting date

Source Natural Foods &Herbal Supplem. will hold a meeting of the Board of Directors of the...

Read more

02 Sep 2024 17:31

News

Source Natural Foods &Herbal Supplem. announces board meeting date

Source Natural Foods &Herbal Supplem. will hold a meeting of the Board of Directors of the...

Read more

12 Aug 2024 15:27

News

Source Natural Foods &Herbal Supplem. schedules board meeting

Source Natural Foods &Herbal Supplem. will hold a meeting of the Board of Directors of the...

Read more

18 Jun 2024 16:35

BlinkX Score for Source Natural Foods & Herbal Supplements Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Astrazeneca Pharma India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Astrazeneca Pharma India Ltd and Source Natural Foods & Herbal Supplements Ltd

Which company has a larger market capitalization, Astrazeneca Pharma India Ltd or Source Natural Foods & Herbal Supplements Ltd?

Market cap of Astrazeneca Pharma India Ltd is 19,980 Cr while Market cap of Source Natural Foods & Herbal Supplements Ltd is 103 Cr

What are the key factors driving the stock performance of Astrazeneca Pharma India Ltd and Source Natural Foods & Herbal Supplements Ltd?

The stock performance of Astrazeneca Pharma India Ltd and Source Natural Foods & Herbal Supplements Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Astrazeneca Pharma India Ltd and Source Natural Foods & Herbal Supplements Ltd?

As of May 10, 2025, the Astrazeneca Pharma India Ltd stock price is INR ₹7992.35. On the other hand, Source Natural Foods & Herbal Supplements Ltd stock price is INR ₹160.95.

How do dividend payouts of Astrazeneca Pharma India Ltd and Source Natural Foods & Herbal Supplements Ltd compare?

To compare the dividend payouts of Astrazeneca Pharma India Ltd and Source Natural Foods & Herbal Supplements Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions